These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

536 related items for PubMed ID: 870690

  • 1. Exogenous estrogens and endometrial carcinoma: review and comments for the clinician.
    Berger GS, Fowler WC.
    J Reprod Med; 1977 Apr; 18(4):177-80. PubMed ID: 870690
    [Abstract] [Full Text] [Related]

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Apr; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 3. Review of epidemiologic studies of endometrial cancer and exogenous estrogen.
    Cramer DW, Knapp RC.
    Obstet Gynecol; 1979 Oct; 54(4):521-6. PubMed ID: 492641
    [Abstract] [Full Text] [Related]

  • 4. Estrogens for the menopause. Maximizing benefits, minimizing risks.
    Seller JC.
    Postgrad Med; 1977 Sep; 62(3):73-9. PubMed ID: 197509
    [Abstract] [Full Text] [Related]

  • 5. Update on estrogens and uterine cancer.
    FDA Drug Bull; 1979 Sep; 9(1):2-3. PubMed ID: 428701
    [Abstract] [Full Text] [Related]

  • 6. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR, Gadducci A, Gambacciani M.
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [Abstract] [Full Text] [Related]

  • 7. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The adverse effects of hormonal therapy.
    Bush TL.
    Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
    [Abstract] [Full Text] [Related]

  • 10. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE.
    Acta Endocrinol (Copenh); 1991 Feb; 125 Suppl 1():13-26. PubMed ID: 1801500
    [Abstract] [Full Text] [Related]

  • 11. Estrogen use and postmenopausal women.
    United States. National Institute on Aging.
    NIH Consens Dev Conf Summ; 1979 Feb; 2(8):1-5. PubMed ID: 12336054
    [Abstract] [Full Text] [Related]

  • 12. Uterine cancer and estrogen therapy.
    Mack TM.
    Front Horm Res; 1977 Feb; 5():104-16. PubMed ID: 614940
    [Abstract] [Full Text] [Related]

  • 13. Estrogens and endometrial carcinoma.
    Gray LA, Christopherson WM, Hoover RN.
    Obstet Gynecol; 1977 Apr; 49(4):385-9. PubMed ID: 193072
    [Abstract] [Full Text] [Related]

  • 14. Editorial: Cancer risk and estrogen use in the menopause.
    Ryan KJ.
    N Engl J Med; 1975 Dec 04; 293(23):1199-200. PubMed ID: 1186792
    [Abstract] [Full Text] [Related]

  • 15. Postmenopausal carcinoma as a result of estrogen treatment: survey of evidence.
    Mack TM.
    Pediatrics; 1978 Dec 04; 62(6 Pt 2):1104-13. PubMed ID: 724347
    [Abstract] [Full Text] [Related]

  • 16. Estrogen prescribing practices scrutinized at NIH conference.
    Eichelberger BM.
    Am J Hosp Pharm; 1979 Dec 04; 36(12):1728. PubMed ID: 525651
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Links between hormone replacement therapy and neoplasia.
    Hulka BS.
    Fertil Steril; 1994 Dec 04; 62(6 Suppl 2):168S-175S. PubMed ID: 7958013
    [Abstract] [Full Text] [Related]

  • 20. Oestrogens and endometrial hyperplasia.
    Thom MH, Studd JW.
    Br J Hosp Med; 1980 May 04; 23(5):506, 508-9, 511-3. PubMed ID: 6992895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.